Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2001;77:157-165; doi:10.1136/pmj.77.905.157
© 2001 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.
Postgrad Med J 2001;77:157-165 ( March )

Review

Pregnancy in systemic lupus erythematosus C C Moka, R W S Wongb

a Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, b Department of Medicine, Queen Mary Hospital, Hong Kong

Correspondence to: Dr Chi Chiu Mok, Department of Medicine and Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong ccmok{at}netvigator.com

Submitted 1 March 2000; Accepted 14 August 2000

Systemic lupus erythematosus (SLE) is an autoimmune disease that predominantly affects women of reproductive age. Pregnancy and its outcome is a major concern to most SLE patients. Queries regarding the risk of disease flares during pregnancy, chance of fetal loss, and the safety of various drugs are often raised. With the improvement in the understanding of the pathogenesis of SLE and the judicious use of immunosuppressive drugs, better disease control can now be achieved and SLE patients should not be deprived of the opportunity for bearing children. Prepregnancy counselling and close collaboration with other specialists such as the obstetricians and the perinatologists is essential in optimising the maternal and fetal outcome in lupus pregnancies. In this review, important issues regarding the fertility rate, optimal timing of conception, risk of disease flares during lupus pregnancy, pregnancy course, fetal outcome, safety of various drugs used for disease control during pregnancy and lactation, and contraceptive advice are discussed.


Keywords: systemic lupus erythematosus; pregnancy; flare; hormone


© 2001 by The Fellowship of Postgraduate Medicine

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Perricone, R., De Carolis, C., Kroegler, B., Greco, E., Giacomelli, R., Cipriani, P., Fontana, L., Perricone, C. (2008). Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford) 47: 646-651 [Abstract] [Full Text]  
  • Gayed, M., Gordon, C. (2007). Pregnancy and rheumatic diseases. Rheumatology (Oxford) 46: 1634-1640 [Abstract] [Full Text]  
  • Kong, N. C. T. (2006). Pregnancy of a lupus patient--a challenge to the nephrologist. Nephrol Dial Transplant 21: 268-272 [Full Text]  
  • Clowse, M E., Magder, L, Petri, M (2005). Cyclophosphamide for lupus during pregnancy. Lupus 14: 593-597 [Abstract]  
  • Mok, C C, Lau, C S (2003). Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 56: 481-490 [Abstract] [Full Text]  
  • Ioannou, Y, Isenberg, D A (2002). Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge. Postgrad. Med. J. 78: 599-606 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.